Pioneering Breath Analysis Technology Achieves Patent Milestone
VANCOUVER, British Columbia — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) is excited to share that the United States Patent and Trademark Office has granted a notice of allowance for its patent application, which showcases their innovative work in breath analysis technology.
Understanding the Contactless Breath Analysis Device
This patent application focuses on Cannabix’s cutting-edge contactless breath capture and analysis technology, which offers a dual mode for both contactless and traditional mouthpiece testing. This versatile system provides rapid and dependable testing options without any physical contact. It can effortlessly integrate into various environments, from vehicles to workplaces and even public kiosks.
Real-time Feedback and Applications
The technology is designed to function seamlessly in unmanned breath testing devices, giving immediate feedback through visual indicators. It is particularly valuable in law enforcement settings, workplace safety initiatives, and public health monitoring. The system dynamically adjusts its internal airflow and pump mechanisms based on the selected sampling method, ensuring both accurate and hygienic testing results.
Enhancing Cannabix’s Leadership in Breath Analysis
The approval of this patent application strengthens Cannabix’s position as a leader in breath sampling techniques. By developing robust intellectual property in the field of breath analysis, Cannabix is advancing its capabilities in delivering effective testing solutions for delta-9 THC, the principal psychoactive compound in cannabis. This is particularly relevant in contexts where discerning recent marijuana use is crucial.
The BreathLogix Device
In addition to the recent patent, Cannabix has also developed the BreathLogix autonomous alcohol screening device. This technology aims to improve alcohol safety and monitoring in various organizations, showcasing Cannabix’s commitment to public health and safety through innovative solutions.
What’s Next for Cannabix Technologies Inc.?
While the notice of allowance signifies a step forward, it is important to note that this does not equate to an official patent grant. Cannabix will keep stakeholders updated on any material developments related to its contact-free breath analysis device and method. The continual evolution of their technology reflects their dedication to advancing the field of breath testing.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is at the forefront of developing breath analysis technologies that cater to workplaces, law enforcement, and public health sectors. Their mission is to innovate and enhance testing for cannabis and alcohol, ensuring safety and compliance across various environments.
Frequently Asked Questions
What technology has Cannabix Technologies developed?
Cannabix Technologies has developed a contactless breath analysis device that can be used in various environments for testing THC and alcohol levels.
What recent achievement did Cannabix secure?
The company received a notice of allowance from the USPTO for their patent application regarding their breath analysis technology.
How does the breath analysis technology work?
The technology uses dual-mode systems for contactless testing, ensuring accuracy and hygiene, with real-time feedback through visual aids.
Who benefits from Cannabix Technologies' devices?
Law enforcement, workplaces, and public health agencies can significantly benefit from the breath testing devices developed by Cannabix.
What is the BreathLogix device?
The BreathLogix device is an autonomous alcohol screening tool developed to enhance monitoring and safety regarding alcohol use in organizations.
